Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers

  • Unicycive Therapeutics, Inc. UNCY shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb.
  • BridgeBio Pharma, Inc. BBIO shares jumped 59.5% to $17.34 after the company announced positive data for its phase 2 study of Infigratinib in Achondroplasia.
  • Avalon GloboCare Corp. ALBT shares gained 53.5% to $3.3330.
  • Azul S.A. AZUL gained 45.3% to $6.05 after the company announced a deal to reduce the immediate cash it must expend for leased property.
  • Kala Pharmaceuticals, Inc. KALA rose 28.3% to $21.49. HC Wainwright & Co. maintained Kala Pharmaceuticals with a Buy and raised the price target from $12 to $20.Kala Pharmaceuticals recently said Q4 adjusted EPS results were higher year over year.
  • TCR2 Therapeutics Inc. TCRR gained 28% to $1.55 after the company and Adaptimmune announced a strategic combination to create a preeminent cell therapy company for solid tumors.
  • Bellerophon Therapeutics, Inc. BLPH surged 25% to $2.28. Bellerophon Therapeutics announced a $5 million registered direct offering with institutional investor.
  • Genius Group Limited GNS gained 22.5% to $4.4493.
  • Entera Bio Ltd. ENTX rose 22.1% to $1.2206 after dropping 5% on Friday. Entera Bio recently announced the FDA's acceptance of a Type D meeting review to affirm design of the pivotal, Phase 3 protocol for EB613 PTH mini tablets, as the first oral osteoanabolic treatment of post-menopausal osteoporosis.
  • Gol Linhas Aéreas Inteligentes S.A. GOL gained 21.8% to $2.51 amid strong Brazilian air travel numbers.
  • Orchard Therapeutics plc ORTX jumped 21.3% to $0.57 after the company posted a narrower quarterly loss.
  • Borqs Technologies, Inc. BRQS gained 17.2% to $0.2810. Borqs sees preliminary FY22 revenue of $53 million to $58 million.
  • Bellicum Pharmaceuticals, Inc. BLCM jumped 17% to $0.9920.
  • Motorsport Games Inc. MSGM jumped 16% to $11.16. Motorsport Games recently announced a $4.03 million registered direct offering.
  • Armata Pharmaceuticals, Inc. ARMP gained 15.8% to $3.20 after the company announced topline data from the Phase 1b/2a SWARM-P.a. clinical trial of inhaled AP-PA02 in patients with cystic fibrosis.
  • Troika Media Group, Inc. TRKA rose 15.6% to $0.5968 after dropping over 4% on Friday.
  • Snap Inc. SNAP gained 11.3% to $11.85.
  • BYND Cannasoft Enterprises Inc. BCAN rose 9.4% to $2.7251 after declining around 3% on Friday.
  • Secoo Holding Limited SECO rose 7.5% to $1.0750 after dipping over 31% on Friday.
  • Hertz Global Holdings, Inc. HTZ shares rose 7.4% to $20.18. Hertz Global will replace Pebblebrook Hotel Trust in the S&P MidCap 400 effective Monday, March 20.
  • BuzzFeed, Inc. BZFD rose 6.7% to $1.6540. BuzzFeed is expected to release its Q4 financial results on Monday, March 13, 2023, after the closing bell.

Losers

  • Aclaris Therapeutics, Inc. ACRS shares dipped 54.5% to $5.82 after the company announced its Phase 2A study of Zunsemetinib for Hidradentis Suppurativa did not meet its primary or secondary endpoints.
  • Embark Technology, Inc. EMBK dropped 32.4% to $2.56. On March 1, 2023, Embark Technology board approved a reduction in its current workforce by approximately 230 employees.
  • Recon Technology, Ltd. RCON fell 27.7% to $1.3073.
  • Rubius Therapeutics, Inc. RUBY fell 22.3% to $0.0970 after gaining 10% on Friday.
  • Esperion Therapeutics, Inc. ESPR fell 22% to $4.9450 after the company published new data on its treatment to reduce cardiovascular risk.
  • Yoshiharu Global Co. YOSH dropped 21.5% to $1.7190.
  • Digital Media Solutions, Inc. DMS dropped 19.3% to $0.9123. Digital Media Solutions, Inc. signed an agreement to acquire the HomeQuote.io home services marketplace from Customer Direct Group along with their brand direct international ad network.
  • Science 37 Holdings, Inc. SNCE fell 17.7% to $0.2630 after the company posted a Q4 loss and files for mixed shelf of up to $100 million.
  • Adaptimmune Therapeutics plc ADAP dropped 17.3% to $1.4550 after the company announced a strategic combination with TCR2 Therapeutics. The company also reported Q4 financial results.
  • CECO Environmental Corp. CECO dipped 13.3% to $13.50 after the company posted Q4 results.
  • Sidus Space, Inc. SIDU fell 13.1% to $0.76.
  • Performance Shipping Inc. PSHG shares fell 12.5% to $0.9703. Performance Shipping recently reported pricing of $12.5 million registered direct offering.
  • Addex Therapeutics Ltd ADXN dropped 12.1% to $1.6087.
  • ObsEva SA OBSV fell 9.7% to $0.2074. ObsEva shares jumped 117% on Friday following the purchase of 4 million shares by a company director.
  • Unisys Corporation UIS fell 9.1% to $4.4350.
  • Oculis Holding AG OCS dropped 8.3% to $9.98.
  • IAA, Inc. IAA fell 7.6% to $38.06.
  • Vivos Therapeutics, Inc. VVOS shares fell 7.5% to $0.3998 after gaining 11% on Friday. Vivos Therapeutics recently acquired product rights and patents from Advanced Facialdontics, LLC.

Now Read This: Top 5 Utilities Stocks That Could Blast Off In March

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!